These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27496793)

  • 1. Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer.
    Shetty P; Patil VS; Mohan R; D'souza LC; Bargale A; Patil BR; Dinesh US; Haridas V; Kulkarni SP
    Ann Clin Biochem; 2017 Jul; 54(4):463-471. PubMed ID: 27496793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
    David M; Sahay D; Mege F; Descotes F; Leblanc R; Ribeiro J; Clézardin P; Peyruchaud O
    PLoS One; 2014; 9(5):e97771. PubMed ID: 24828490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
    Shetty PK; Thamake SI; Biswas S; Johansson SL; Vishwanatha JK
    PLoS One; 2012; 7(9):e44299. PubMed ID: 22957061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.
    Miyata K; Yotsumoto F; Fukagawa S; Kiyoshima C; Ouk NS; Urushiyama D; Ito T; Katsuda T; Kurakazu M; Araki R; Sanui A; Miyahara D; Murata M; Shirota K; Yagi H; Takono T; Kato K; Yaegashi N; Akazawa K; Kuroki M; Yasunaga S; Miyamoto S
    Anticancer Res; 2017 Jul; 37(7):3955-3960. PubMed ID: 28668900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
    Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
    Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Potent Target for Breast Cancer Therapy.
    Lian C; Ruan L; Shang D; Wu Y; Lu Y; Lü P; Yang Y; Wei Y; Dong X; Ren D; Chen K; Liu H; Tu Z
    Cancer Biother Radiopharm; 2016 Apr; 31(3):85-90. PubMed ID: 27093342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
    Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
    Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation.
    de Graauw M; Cao L; Winkel L; van Miltenburg MH; le Dévédec SE; Klop M; Yan K; Pont C; Rogkoti VM; Tijsma A; Chaudhuri A; Lalai R; Price L; Verbeek F; van de Water B
    Oncogene; 2014 May; 33(20):2610-9. PubMed ID: 23792445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface interaction of annexin A2 and galectin-3 modulates epidermal growth factor receptor signaling in Her-2 negative breast cancer cells.
    Shetty P; Bargale A; Patil BR; Mohan R; Dinesh US; Vishwanatha JK; Gai PB; Patil VS; Amsavardani TS
    Mol Cell Biochem; 2016 Jan; 411(1-2):221-33. PubMed ID: 26438086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentrations of growth factors and activation of the EGFR system in breast cancer.
    Olsen DA; Bechmann T; Østergaard B; Wamberg PA; Jakobsen EH; Brandslund I
    Clin Chem Lab Med; 2012 Oct; 50(10):1809-18. PubMed ID: 23089711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
    Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer.
    Yotsumoto F; Oki E; Tokunaga E; Maehara Y; Kuroki M; Miyamoto S
    Int J Cancer; 2010 Dec; 127(11):2707-17. PubMed ID: 20499311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
    Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.
    Chaudhary P; Thamake SI; Shetty P; Vishwanatha JK
    Br J Cancer; 2014 Dec; 111(12):2328-41. PubMed ID: 25321192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.